BillionToOne receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BillionToOne Inc (BLLN)
BillionToOne Inc stock price live, this page displays NASDAQ BLLN stock exchange data. View the BLLN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the BillionToOne Inc real time stock price chart below.
What Is the BillionToOne Inc Stock Price Today?
The BillionToOne Inc stock price today is 92.90.
What Is the Stock Symbol for BillionToOne Inc?
The stock symbol for BillionToOne Inc is "BLLN."
What Stock Exchange Does BillionToOne Inc Trade On?
BillionToOne Inc is listed and trades on the NASDAQ stock exchange.
Is BillionToOne Inc a Good Stock to Buy?
Determining whether BillionToOne Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BLLN quote. (ISIN: US0901681058) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
What Is the BillionToOne Inc Stock Price Today?
The BillionToOne Inc stock price today is 92.90.
What Is the Stock Symbol for BillionToOne Inc?
The stock symbol for BillionToOne Inc is "BLLN."
What Stock Exchange Does BillionToOne Inc Trade On?
BillionToOne Inc is listed and trades on the NASDAQ stock exchange.
Is BillionToOne Inc a Good Stock to Buy?
Determining whether BillionToOne Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BLLN quote. (ISIN: US0901681058) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
Fair Value
An estimate of a BillionToOne's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
77.10
93.00
52 wk Range
61.96
138.70
Unusual trading volume
1/2
Fair Value
An estimate of a BillionToOne's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
77.1093.00
52 wk Range
61.96138.70
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BLLN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a BillionToOne's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
116.00
Upside
+24.87%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- BillionToOne appoints Allen Chen as oncology VP
- Investing.com
- BillionToOne receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- BillionToOne receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 116.00
(+24.87% Upside)
BillionToOne Inc Earnings Call Summary for Q1/2026
- Q1 2026 revenue surged 84% YoY to $108.4M; EPS turned positive at $0.34 vs. $(0.39) loss in Q1 2025; gross margin expanded to 73% from 64%.
- Prenatal segment revenue grew 72% to $97.7M; oncology revenue skyrocketed nearly 400% YoY to $10.7M, driving diversified growth momentum.
- Operating income reached $17.8M, reversing prior-year loss of $2.3M; cash position strengthened to $537.5M at quarter-end.
- Full-year revenue guidance raised to $450-$465M, implying 48%-52% growth; launched Unity Confirm prenatal testing platform as strategic milestone.
- Stock traded at $80 aftermarket (+1.88%); faces risks from clinical trial delays, competitive pressures, and reimbursement uncertainties.
Last Updated: 06/05/2026, 22:38
Read Full TranscriptEarnings
Latest Release
May 06, 2026
EPS / Forecast
0.34 / --
Revenue / Forecast
108.39M / --
Compare BLLN to Peers and Sector
Metrics to compare | BLLN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBLLNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 171.8x | −4.2x | −0.6x | |
PEG Ratio | 12.41 | −0.20 | 0.00 | |
Price/Book | 8.5x | 2.6x | 2.6x | |
Price / LTM Sales | 12.1x | 0.9x | 3.2x | |
Upside (Analyst Target) | 47.4% | 46.9% | 48.1% | |
Fair Value Upside | Unlock | 35.9% | 5.8% | Unlock |
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the BillionToOne (BLLN) Stock Price Today?
The BillionToOne stock price today is 92.90 USD.
What Stock Exchange Does BillionToOne Trade On?
BillionToOne is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for BillionToOne?
The stock symbol for BillionToOne is "BLLN."
What Is the BillionToOne (BLLN) Afterhours Price Today? (Afterhours variable test: 90.19) Current Date: May 08, 2026
After hours price: 90.19. After hours price change (units): -2.71. Price change percentage: -2.91%
What Is the BillionToOne Market Cap?
As of today, BillionToOne market cap is 4.27B USD.
What Is BillionToOne's Earnings Per Share (TTM)?
The BillionToOne EPS (TTM) is 1.00.
When Is the Next BillionToOne Earnings Date?
BillionToOne will release its next earnings report on May 06, 2026.
From a Technical Analysis Perspective, Is BLLN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has BillionToOne Stock Split?
BillionToOne has split 0 times.
How Many Employees Does BillionToOne Have?
BillionToOne has 713 employees.
What is the current trading status of BillionToOne (BLLN)?
As of May 08, 2026, BillionToOne (BLLN) is trading at a price of 92.90 USD, with a previous close of 92.90 USD. The stock has fluctuated within a day range of 77.10 USD to 93.00 USD, while its 52-week range spans from 61.96 USD to 138.70 USD.
What Is BillionToOne (BLLN) Price Target According to Analysts?
The average 12-month price target for BillionToOne is 116.00 USD, with a high estimate of 145 USD and a low estimate of 90 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +24.87% Upside potential.
What Is the BLLN After Hours Price?
BLLN's last after hours stock price is 90.19 USD, the stock has decreased by -2.71, or -2.91%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.